Intelligence · Clinical Pipeline

First People's Hospital Pipeline

All ClinicalTrials.gov programs at First People's Hospital — phase, modality, and trial IDs.

Programs
186

Quick answer

First People's Hospital has 186 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Dexmedetomidine-esketamine combination

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule active

    1 trial
  2. Diane-35 pretreatment

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    approved small molecule active

    1 trial
  3. Edaravone dexborneol

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule active

    1 trial
  4. Esketamine

    The First People's Hospital of Lianyungang

    Scoliosis Correction

    approved small molecule active

    1 trial
  5. Esketamine

    The First People's Hospital of Lianyungang

    Postpartum Depression

    approved small molecule active

    1 trial
  6. Esketamine 0.2 mg/kg

    The First People's Hospital of Lianyungang

    Cesarean Delivery

    approved small molecule completed

    1 trial
  7. Esketamine 1

    The First People's Hospital of Lianyungang

    Elderly

    approved small molecule active

    1 trial
  8. Esketamine combined with dexmedetomidine

    The First People's Hospital of Lianyungang

    Dexmedetomidine

    approved small molecule active

    2 trials
  9. Exenatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial
  10. Flumatinib

    The First People's Hospital of Lianyungang

    Flumatinib

    approved small molecule active

    1 trial
  11. Folic Acid

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial
  12. Fosinopril

    The First People's Hospital of Lianyungang

    Chronic Kidney Disease

    approved small molecule active

    1 trial
  13. Glucagon-like peptide-1 receptor agonist:Semaglutide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial
  14. Glycopyrronium in Combination With Tropisetron

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    approved small molecule completed

    1 trial
  15. Henagliflozin Proline Tablets treatment

    The First People's Hospital of Lianyungang

    Diabetes Type 2

    approved small molecule active

    1 trial
  16. High-dose anrikefon

    The First People's Hospital of Lianyungang

    Laparoscopic Surgery

    approved small molecule active

    2 trials
  17. Honghe Fujie lotion

    The First People's Hospital of Lianyungang

    Bacterial Vaginitis

    approved small molecule active

    1 trial
  18. Hydroxychloroquine Sulfate

    The First People's Hospital of Lianyungang

    Primary IgA Nephropathy

    approved small molecule completed

    1 trial
  19. Hydroxychloroquine Sulfate 200 Mg Tablet

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial
  20. ICS/LABA

    The First People's Hospital of Lianyungang

    Asthma

    approved small molecule active

    1 trial
  21. IVC

    The First People's Hospital of Lianyungang

    Proliferative Diabetic Retinopathy

    approved small molecule active

    1 trial
  22. Icodextrin Peritoneal Dialysis Solution

    The First People's Hospital of Lianyungang

    Peritoneal Dialysis

    approved small molecule active

    1 trial
  23. Individual ATG

    The First People's Hospital of Lianyungang

    Hematopoietic Stem Cell Transplantation

    approved small molecule active

    1 trial
  24. Infliximab

    The First People's Hospital of Lianyungang

    Crohn's Diseases

    approved small molecule active

    1 trial
  25. Insulin

    The First People's Hospital of Lianyungang

    Brain Injuries

    approved small molecule active

    1 trial
  26. Insulin

    The First People's Hospital of Lianyungang

    Acute Pancreatitis

    approved small molecule active

    1 trial
  27. Intranasal dexmedetomidine-esketamine

    The First People's Hospital of Lianyungang

    Adenotonsillectomy

    approved small molecule active

    1 trial
  28. Intravenous Immunoglobulins, Human

    The First People's Hospital of Lianyungang

    Guillain-Barre Syndrome

    approved small molecule active

    1 trial
  29. Intravenous thrombolysis + edaravone

    The First People's Hospital of Lianyungang

    Ischemic Stroke

    approved small molecule active

    1 trial
  30. Irinotecan liposomes combined with cisplatin/carboplatin

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    approved small molecule active

    1 trial
  31. Ixazomib

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    approved small molecule completed

    1 trial
  32. JAK Inhibitor

    The First People's Hospital of Lianyungang

    Dermatomyositis, Adult Type

    approved small molecule active

    1 trial
  33. KANG FU PEN

    The First People's Hospital of Lianyungang

    Cervical Cancer

    approved small molecule active

    1 trial
  34. Keverprazan

    The First People's Hospital of Lianyungang

    H. Pylori Infection

    approved small molecule active

    1 trial
  35. Lecanemab 10 mg/kg

    The First People's Hospital of Lianyungang

    Alzheimer s Disease

    approved small molecule active

    1 trial
  36. Levocarnitine Injection

    The First People's Hospital of Lianyungang

    Renal Dialysis

    approved small molecule completed

    1 trial
  37. Levothyroxine

    The First People's Hospital of Lianyungang

    Heart Failure

    approved small molecule active

    1 trial
  38. Live Combined Bifidobacterium and Lactobacillus

    The First People's Hospital of Lianyungang

    Functional Constipation

    approved small molecule active

    1 trial
  39. Longidaza

    The First People's Hospital of Lianyungang

    Bacterial Vaginosis

    approved small molecule active

    1 trial
  40. Low dose Oliceridine

    The First People's Hospital of Lianyungang

    Oliceridine

    approved small molecule active

    1 trial
  41. Maggot debridement therapy

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcers

    approved other active

    1 trial
  42. Mesalazine

    The First People's Hospital of Lianyungang

    Ulcerative Colitis, Unspecified

    approved small molecule active

    1 trial
  43. Methimazole

    The First People's Hospital of Lianyungang

    Graves Disease

    approved small molecule active

    1 trial
  44. Minocycline

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    2 trials
  45. Montelukast

    The First People's Hospital of Lianyungang

    Sinusitis

    approved small molecule completed

    1 trial
  46. Nerve block with liposomal bupivacaine and intravenous analgesia

    The First People's Hospital of Lianyungang

    Liposomal Bupivacaine

    approved other active

    1 trial
  47. Nifedipine GITS

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial
  48. Nocardia rubra Cell Wall Skeleton

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcer

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does First People's Hospital have?

186 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs